Skip to content
2000
Volume 1, Issue 1
  • ISSN: 1574-8871
  • E-ISSN: 1876-1038

Abstract

Actinic keratoses (AKs) are evolving malignant cutaneous neoplasms. They are also known as solar keratosis, squamous cell carcinoma in situ-solar keratotic type, or keratinocytic intraepidermal neoplasia. Actinic keratoses can be treated by two general methods: by physical/destructive methods and with topical therapies. This article will review current and evolving topical therapeutic options for AKs. Several topical treatment options have been shown to offer some significant benefit in the alleviation of these lesions. The therapies include 5-fluorouracil, imiquimod, diclofenac, colchicine and retinoids.

Loading

Article metrics loading...

/content/journals/rrct/10.2174/157488706775246166
2006-01-01
2025-09-17
Loading full text...

Full text loading...

/content/journals/rrct/10.2174/157488706775246166
Loading

  • Article Type:
    Research Article
Keyword(s): 5-fluorouracil; Diclofenac; Imiquimod; immunomodulator; pharmacokinetics; polymerization
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test